BACKGROUND: Over the past 2 decades the characteristics of women giving birth in the United States and the nature of the births themselves have changed dramatically, with increases in older maternal age, plural births, cesarean deliveries, and conception from infertility treatment. OBJECTIVE: We sought to evaluate the risk of severe maternal morbidity by maternal fertility status, and for in vitro fertilization pregnancies, by oocyte source and embryo state combinations. STUDY DESIGN: Women in 8 states who underwent in vitro fertilization cycles resulting in a live birth during 2004 through 2013 were linked to their infant's birth certificates; a 10:1 sample of births from non-in vitro fertilization deliveries were selected for comparison; those with an indication of infertility treatment on the birth certificate were categorized as subfertile, all others were categorized as fertile. In vitro fertilization pregnancies were additionally categorized by oocyte source (autologous vs donor) and embryo state (fresh vs thawed). Maternal morbidity was identified from the birth certificate, modeled using logistic regression, and reported as adjusted odds ratios [95% confidence intervals]. The reference group was fertile women. RESULTS: The study population included 1,477,522 pregnancies (1,346,118 fertile, 11,298 subfertile, 80,254 in vitro fertilization autologous-fresh, 21,964 in vitro fertilization autologous-thawed, 13,218 in vitro fertilization donor-fresh, and 4670 in vitro fertilization donorthawed pregnancies): 1,420,529 singleton, 54,573 twin, and 2420 tripletþ pregnancies. Compared to fertile women, subfertile and the 4 groups of in vitro fertilizationetreated women had increased risks for blood transfusion and third-or fourth-degree perineal laceration (subfertile, The risks of severe maternal morbidity are increased for subfertile and in vitro fertilization births, particularly in pregnancies that are not from autologous, fresh cycles.
The risks of severe maternal morbidity are increased for subfertile and in vitro fertilization births, particularly in pregnancies that are not from autologous, fresh cycles.
Introduction
Births in the United States from in vitro fertilization (IVF) have doubled from 2000 through 2015, and currently account for 1.8% of all births.
1e4 Although the use of autologous oocytes and fresh embryos has been the norm since IVF treatment began in the 1980s, in recent years there has been a national and international shift in practice to freezeonly, believed to provide better endometrial development than the controlled ovarian stimulation required with autologous-fresh transfers. 5e9 While there is growing evidence from clinical studies that the freeze-only approach is associated with better rates of implantation, clinical pregnancy, ongoing pregnancy, and live birth with thawed vs fresh embryo transfers, 10e12 little is known regarding the consequences at delivery.
Although an estimated 12% of reproductive-aged women and 9.4% of reproductive-aged men have ever used infertility services, IVF represents only a small portion of all infertility treatment used in the United States. Results of the 2006 through 2010 National Survey of Family Growth reported that the most commonly used infertility services among women ages 25e44 years included medical advice (9.4%), infertility testing (male or female, 7.3%), medical help to prevent miscarriage (6.8%), and ovulation drugs (5.8%). Artificial insemination was reported by 1.7% of women ages 25e44 years (w714,000 women), and surgery for blocked tubes by 1.3% of women (w531,000). Assisted reproductive technology (ART), including IVF, was the least common service ever used, reported by 0.7% of women ages 25e44 years (w275,000 women). 13 Among women with current infertility problems, an estimated 3.1% had ever used ART. The purpose of this analysis is to 
Materials and Methods
This study involved linking data from the national IVF database, the Society for Assisted Reproductive Technology (SART) Clinic Outcome Reporting System (CORS), to birth certificates as part of a larger study in 14 states on ART and risk of childhood cancer (National Institutes of Health grant R01 CA151973). The data for this analysis were limited to live births (22 weeks' gestation and 300 g birthweight) to mothers at least 18 years of age in study states in which the 2003 revision of the birth certificate had been implemented and its data available (California, Colorado, Florida, Michigan, New York, Ohio, Pennsylvania, and Texas).
SART CORS data
The SART maintains Health Insurance Portability and Accountability Act of 1996ecompliant Business Associate Agreements with its 375 reporting clinics. In 2004, following a contract change with the Centers for Disease Control and Prevention, SART leveraged the SART CORS data for the purposes of conducting research. The database includes information on demographic factors, IVF diagnoses and treatment parameters, and pregnancy outcomes. The data in the SART CORS are validated annually with some clinics having on-site visits for chart review. During each visit, data reported by the clinic are compared with information recorded in the medical record; most data fields have discrepancy rates <2%, with diagnosis fields ranging from 2e5%. 14 
Birth certificate data
The 2003 revision of the birth certificate includes specific severe maternal morbidities occurring within 24 hours before or after delivery: maternal transfusion; third-or fourth-degree perineal laceration (vaginal births); ruptured uterus; unplanned hysterectomy; and admission to intensive care. Also in the 2003 revision of the birth certificate, 3 check boxes were added to indicate: (1) the pregnancy resulted from infertility treatment ("if yes, check all that apply"); (2) fertility-enhancing drugs, artificial insemination, or intrauterine insemination; and (3) ART (eg, IVF, gamete intrafallopian transfer). Pregnancies that linked to the SART CORS cycles were categorized as IVF; pregnancies with an indication that they resulted from infertility treatment (via the infertility check box) but did not link to an IVF cycle were categorized as subfertile; the remaining pregnancies were categorized as fertile.
Linkage procedure
In the course of conducting a study on childhood cancer following IVF, we linked the SART CORS data and state vital records. Each state received a file of cycles of women who were residents of that state. To begin the linkage process, a limited data file was generated by Redshift Technologies Inc (New York, NY), the organization that maintains the CORS on behalf of SART, containing only the following factors: study-specific patient identification (ID) and cycle ID; woman's first name, middle name or initial, and last names; Social Security number; date of birth; ZIP code of residence; date of cycle outcome (live birth); plurality of the live birth; and gender(s) and birthweight(s) of the infant(s). The state then performed a linkage to identify the IVF births; 91% of IVF-conceived births in the SART CORS were linked to their respective birth certificates. For each delivery identified as having been conceived by IVF, we requested that the subsequent 10 deliveries (all liveborn infants from a pregnancy) be selected as the non-IVF comparison group, although not all states implemented this request, providing the next 10 births (individual children) instead, and often only 1 infant from a twin or tripletþ pregnancy. The files of the study children were then linked to each state's vital records. Once all data were linked and complete, the files were stripped of all identifying elements (eg, names, dates, Social Security numbers, and any other information that could identify an individual), but retaining the patient ID and cycle ID for the IVF group. The deidentified files were then transmitted to the investigators using secure file transfer methods. For the investigators, Redshift Technologies Inc created a deidentified data file with the study-specific patient ID and cycle ID, and the IVF treatment parameters, and sent the file by secure transfer methods. We then merged the 2 deidentified data files using the patient ID and cycle ID. This study was approved by the institutional review boards at Michigan State University, the University of Michigan, the University of Minnesota, and each of the state departments of health.
The data files received from the states were indexed by infant. However, in this study the analysis was by mother.
AJOG at a Glance
Why was this study conducted? To evaluate the risks of severe maternal morbidity by maternal fertility status and plurality.
Key findings Among the total study population, the risk of blood transfusion was increased for the subfertile group and the 4 in vitro fertilization groups; the risk of unplanned hysterectomy was increased for autologous-thawed, donor-fresh, and donorthawed groups. Risk of ruptured uterus was increased for the autologous-fresh group.
What does this add to what is known?
The risks of severe maternal morbidity are increased for subfertile and in vitro fertilizationetreated women, particularly in pregnancies that are not from autologous, fresh cycles.
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Comparison groups
Women were classified as IVF-treated only if the state matched the subject to a record in the SART CORS; >90% of the women in SART CORS were identified by the matching. The IVF-treated subjects were then divided into 4 subgroups depending on the source of the oocyte (autologous or donor) and the state of the embryo (fresh or thawed). The control subjects were divided into 2 groups: fertile and subfertile; a woman was assigned to the subfertile group if she responded positively to any of the infertility questions on the birth certificate. Therefore, 6 maternal fertility status groups were created; the fertile women were treated as the reference group in the modeling.
Variables
Independent variables included maternal age at delivery (continuous and as 18e29, 30e34, 35e37, 38e40, 41e44, and 45 years), race (white, black, Asian, other) and Hispanic ethnicity, education (<8th grade, some high school, high school graduate or General Educational Development, some college or associate degree, bachelor degree, or postgraduate education), hypertension (none, chronic, or either gestational or eclampsia), diabetes mellitus (none, chronic, or gestational), 
Statistical methods
We modeled the risk of each severe morbidity measure and unplanned hysterectomy after vaginal birth and after cesarean birth using logistic regression as adjusted odds ratios (AOR) and 95% confidence intervals controlling for maternal fertility status, age, race and ethnicity, parity, medical conditions (diabetes mellitus and hypertension), plurality at birth, mode of delivery, state of residence, year of birth, and infant sex. For unplanned hysterectomy, we modeled the risk overall and after a vaginal delivery and after a cesarean delivery. We repeated this analysis limited to women with a prior delivery, additionally controlling for prior mode of delivery. For third-or fourthdegree perineal laceration analyses were limited to singleton vaginal births only and the models included length of gestation. Only models with sufficient sample size are presented in the tables. All analyses were performed using software (SAS, Version 9.4).
Results
The Pregnancy, birth, and infant outcomes by maternal fertility group and plurality at birth 
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characteristics by fertility group and plurality are shown in Table 1 . Women in the fertile group were more likely to be younger, Hispanic, and multiparous, and were less likely to be college graduates compared to the subfertile and IVF groups, which for most characteristics tended to be similar. The infertility diagnoses and IVF treatment parameters are shown in Table 2 . Fewer women using fresh embryos had prior IVF cycles, averaging 52.1e61.1% (using autologous oocytes) and 66.8e71.3% (using donor oocytes). Women using thawed embryos were more likely to have had prior IVF cycles, averaging 91.3e92.9% (using autologous oocytes) and 81.8e89.9% (using donor oocytes). Male factor infertility was the most frequent diagnosis among women using autologous oocytes, regardless of embryo state or plurality, accounting for 40e45% of diagnoses. For women using donor oocytes, diminished ovarian reserve was the most common diagnosis, accounting for 72e79% for diagnoses, regardless of embryo state and plurality. Only 12.2e24.1% of singleton IVF births had a single embryo transferred, 65.3e83.5% of twin births had 2 embryos transferred, and 56.3e79.5% of tripletþ births had >2 embryos transferred, indicating probable evidence of fetal loss and embryo splitting.
The pregnancy, birth, and infant outcomes by fertility group and plurality are shown in Table 3 . Subfertile women had the highest rates of gestational diabetes in singleton (9.2%) and twin (10%) births, and any morbidity (2477/100,000 pregnancies) and third-or fourth-degree perineal laceration in singleton and twin births (3477/100,000 pregnancies and 1230/100,000 pregnancies, respectively). Within each fertility group, the rates of third-or fourth-degree perineal laceration were highest among nulliparas (rates for 100,000 pregnancies for fertile, subfertile, and IVF women: nulliparas: 2115, 3990, and 2913, respectively; parity ¼ 1: 593, 1214, and 1075, respectively; and parity 2: 229, 273, and 787, respectively) (data not shown). Women with donor-fresh or donor-thawed cycles had the highest rates of pregestational and gestational hypertension within each TABLE 4 Risks of severe maternal morbidity by maternal fertility status Original Research OBSTETRICS ajog.org plurality. Regardless of fertility group, singleton births were more likely to be delivered vaginally, whereas >74% of twins and >93% of tripletþ births were delivered by cesarean. Within each plurality, fertile women were more likely to deliver vaginally. The results of the logistic regression models of the risks of severe maternal morbidity for the total study population are shown in Table 4 , and limited to women with a prior birth in Table 5 . Among the total study population, compared to fertile women, the risk of blood transfusion and third-or fourthdegree perineal laceration was increased for subfertile and each of the 4 oocyte source-embryo state IVF groups. The risk of unplanned hysterectomy and hysterectomy after cesarean delivery was increased for the IVF groups with autologousthawed, donor-fresh, and donor-thawed. Ruptured uterus was elevated for the autologous-fresh IVF group compared to fertile women.
The pattern was similar among women with a prior delivery, with some risks magnified ( Table 5 ). The risk of blood transfusion after vaginal delivery was increased for subfertile and all 4 groups of IVF-treated women; the risk after cesarean was increased for the autologous-thawed and donor-fresh groups. The risk of unplanned hysterectomy was increased for pregnancies from autologous-thawed and donorthawed cycles.
Comment

Main findings
Defined as unexpected outcomes of labor and delivery that result in significant short-or long-term consequences to a woman's health, severe maternal morbidity affects an estimated 52,000 women annually in the United States. 15, 16 These analyses demonstrate that the risks of severe maternal morbidity are increased for subfertile and IVFtreated women, particularly in pregnancies that are not from autologous, fresh cycles. These data suggest that adverse maternal outcomes associated with IVF may be at least in part due to underlying infertility.
In analyses adjusted for potential confounders, the risks of unplanned hysterectomy were highest among pregnancies achieved with thawed embryos (AORs of 2.76 for autologous oocytes and 2.05 for donor oocytes for the total population [ Table 4 ], and 2.31 for autologous oocytes and 2.45 for donor oocytes for parous women [ Table 5 ]).
Clinical implications
In IVF cycles without ovarian hyperstimulation, such as frozen or donor cycles, there is a lower risk of ectopic pregnancy, suggesting that factors influencing the tubal-uterine environment may influence abnormal implantation.
17e19 Unlike autologousfresh cycles, neither thawed embryo cycles nor donor oocyte involve ovarian hyperstimulation in the recipient woman. Londra et al 19 hypothesize that ovarian hyperstimulation results in a uterine environment that increases the risk of endometrial implantation failure and an abnormally located implantation compared with embryo transfer without ovarian hyperstimulation. While clinical studies have reported better rates of implantation, clinical pregnancy, ongoing pregnancy, and live birth with frozen vs fresh embryo transfers, 11, 18, 20 these cycles have consistently been associated with increased risks for Although our study does not have data on abnormal placentation, the risk of blood transfusion was increased for the subfertile group and all 4 IVF groups in analyses based on the total population (Table 4) , and in vaginal births among parous women (Table 5 ). The risk of unplanned hysterectomy was increased in autologous-thawed and donor-fresh and donor-thawed groups in the total population (Table 4) , and after cesarean birth in autologous-thawed and donorthawed groups among parous women (Table 5) .
A consistent finding in IVF-and ART-conceived pregnancies is an increased risk of uterine bleeding and placental complications, regardless of plurality, and a greater risk for blood transfusions.
24e29 Our results confirm the higher risk of blood transfusions in both subfertile and IVF-conceived pregnancies, and greater likelihood of unplanned hysterectomy in IVFconceived births, particularly in pregnancies that are not from autologous, fresh cycles. In their analysis of all births in Norway in 1999 through 2009, Ebbing et al 27 reported increased risks for velamentous and marginal cord insertions with ART (2-fold for singletons, and 4-fold for twins), and a 20e80% risk of recurrence. The subfertility group in our study, although similar to the IVF group in demographic characteristics, generally showed higher rates of severe maternal morbidity, more consistently in twin and tripletþ births. Unlike IVF cycles, identifying non-IVF ART treatments is challenging, as there is no national registry for these treatments. These women may have received IVF treatment from clinics that did not report to either SART (about 17% of all clinics and 9% of all IVF cycles) or the Centers for Disease Control and Prevention (35 out of 499 clinics in 2015), representing less standardized therapy. They may differ in other ways that were not measured in this study, including socioeconomic, anthropometric, and financial factors.
Higher plurality, which is more frequent in subfertile and IVF pregnancies, is a well-established factor for adverse perinatal outcomes, including greater risks for severe maternal morbidity.
30e33 These risks may be related to over-distention of the uterus due to greater fetal number, as well as factors associated with altered placentation in IVF and ART conceptions. Our prior analyses of twin pregnancies (which were additionally linked to hospital discharge data, as well as birth certificates) have reported a 2-fold increased risk of uterine bleeding and placental complications (abruptio placenta, placenta previa, vasa previa) in subfertile and IVF pregnancies. 34 Nationally in the United States, cesarean rates parallel advancing maternal age: in 2015, women aged 40 years were more than twice as likely to deliver by cesarean as women age <20 years (48.4% vs 20.4%).
1 In 2015, the overall low-risk cesarean delivery rate (cesarean delivery among nulliparous women with full-term singletons in a vertex presentation) was 25.8%, ranging from 16.7% for women ages <20 years to 52.0% for women ages 40 years. 1 The use of forceps, vacuum extraction, and vaginal births after cesarean has declined dramatically in recent years. 35, 36 The rise in cesarean births has paralleled the rate of peripartum hysterectomy, an indicator of severe postpartum hemorrhage. 37 An analysis of the 1994 through 2007 Nationwide Inpatient Sample showed a 15% overall increase in peripartum hysterectomy, including a 23% increase due to abnormal placentation and a 130% increase due to uterine atony (primarily associated with cesarean delivery). 37 During this time period, the rate of severe postpartum hemorrhage (with transfusion or hysterectomy) has doubled. 38, 39 Abnormal placentation (placenta accreta, vasa previa, placenta previa, abruptio placenta, and retained placenta) and postpartum hemorrhage from uterine atony are the leading indicators for peripartum hysterectomy.
Strengths and weaknesses
A common problem in observational studies is unmeasured confounders. As can be seen in Table 1 , subjects who underwent infertility treatment (subfertile or IVF) were more likely to be white, non-Hispanic, more educated, and older than the fertile controls. These differences may be indicative of unmeasured confounders, such as income, medical insurance, and prenatal care, which may affect maternal morbidity. Although race, ethnicity, education, and age were included in the logistic models, it is not possible to estimate the effect of the unmeasured confounders on the AORs.
The states reported matches for >90% of the records in the SART CORS database to women who delivered. Misidentifications by the states would have the effect of including non-IVF subjects in the IVF groups; this would reduce the AORs of the IVF groups. Luke et al 40 showed that there is a large underreporting of the use of infertility treatment on the birth certificate. Women who did not report their infertility treatment would be included in the fertile group; this would reduce the AOR of the subfertile group (and of the IVF groups). Therefore, the result of misclassification is to reduce the AORs.
Known limitations of birth certificate data include the unreliability of selected items (eg, maternal weight gain) and the high rate of missing values for other items (eg, father's age and race/ethnicity, maternal height and prepregnancy weight). 1 The validity of birth certificate data using the medical record as the gold standard has been assessed, with most items reported accurately, with high specificity and wide variance in sensitivity, reflecting that if a rare condition was present, it often was not documented, but if the condition was documented, it was likely that it was present. 41, 42 A major strength of this study is that the SART CORS data were collected prior to and separately from the vital statistics data, so we expect no differential misclassification of maternal Original Research OBSTETRICS ajog.org morbidity with respect to IVF. These findings are subject to several limitations. The low frequency of ruptured uterus has been previously documented in studies evaluating hospital discharge data 43 and the severe morbidity measures on the birth certificate, suggesting difficulty in distinguishing between the diagnoses of a ruptured uterus and uterine dehiscence. 44 A recent comparison of the severe maternal morbidity measures on the birth certificate with International Classification of Diseases, Ninth Revision coding in delivery admission hospital discharge data showed that the former are greatly underreported, with sensitivities ranging from 0.11 (blood transfusion in vaginal births) to 0.52 (unplanned hysterectomy after cesarean delivery), and positive predictive values ranging from 0.03e0.90, with highest values for blood transfusion and perineal lacerations. 45 
Conclusion and future research direction
These analyses demonstrate that the risks of severe maternal morbidity are increased for subfertile and IVF-treated women, particularly in pregnancies that are not from autologous, fresh cycles. The findings of >2-fold increased risk of unplanned hysterectomy in thawed IVF cycles warrant further study, particularly given the increasing utilization of frozen embryo transfer including freeze-only cycles. As the characteristics of the childbearing population continue to change, it is important that severe maternal morbidity be monitored and validated on a national basis. n
